User:Chungclan
Eugene S. Chung, MD
PROFESSIONAL POSITIONS
2006- Director of Outcomes at The Heart and Vascular Center at the Christ Hospital, Cincinnati, OH
2006- Associate Professor of Clinical Medicine, The Ohio State Medical School, Division of Cardiology.
2005- Chairman of the Information Technology Committee, EMR implementation Ohio Heart and Vascular Center, Cincinnati, OH
2000- Director of Heart Failure Program, Ohio Heart and Vascular Center, Cincinnati, OH
2000- Associate Medical Director and Director of the Heart Failure Division, The Carl and Edyth Lindner Clinical Trials Center, Cincinnati, OH
1999 Visiting Assistant Professor of Circulatory Physiology and Heart Transplantation, Columbia Presbyterian Hospital, NY, NY
1996-2000 Assistant Professor of Medicine, Division of Cardiology, University of Massachusetts Medical Center
Attending in the Heart Failure Wellness Center. Associate Director of the Heart Failure Wellness Center.
Attending in the Heart Station (non-invasive Cardiology).
Attending in the Cardiac Catheterization Laboratory
________________________________________________________________________________
Peer Reviewed Manuscripts
1. Park CS, Honeyman TH, Chung ES, Lee JS, Sigmon DS, Fray JCS. Involvement of Calmodulin in Mediating Inhibitory Action of Intracellular Calcium on Renin Secretion. Am J Physiol 1986; 251:F1055-F1062.
2. Chung ES, Leeman SE, Cuenoud HF. The Effect of Neonatal treatment with Capsaicin on Focal Arteriolar Insudation. Microvascular Research, 1991;42 (3):316-324.
3. Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG, JR., Meyer TE. Chronic Adenosine Uptake Blockade in Pressure Overload Hypertrophy in the Rat: Effects on Adrenergic Responsiveness and Left Ventricular Chamber Function.. J Hypertension, 1998; Dec 16 (12, pt.1):1813-22.
4. Perlini S, Khoury EP, Norton GR, Chung ES, Fenton RA, Dobson JG, Jr., Meyer TE. Adenosine Mediates Sustained Adrenergic Desensitization in the Rat Heart Via Activation of Protein Kinase C. Circ. Res. 1998; 83 (7):761-771.
5. Mela T, Meyer TE, Pape LA, Chung ES, Aurigemma GP, Weiner BH. Coronary dimension to left ventricular mass ratio is decreased in non-ischemic cardiomyopathy. Am J Cardiol 1999; 83;1277-1280.
6. Norton GR, Woodiwiss AK, McGinn RJ, Lorbar M, Chung ES, Honeyman TW, Fenton RA, Dobson JG, Jr., Meyer TE. Adenosine A2a Receptor Activation Modulates A1 Receptor-Mediated Antiadrenergic Effects in the Rat Myocardium. Am J Physiol 1999; 276: H341-349.
7. Meyer TE, Chung ES, Perlini S, Lorbar M, Norton GR, Woodiwiss AK, Fenton RA, Dobson JG, Jr. Role of Adenosine in a Rat Model of Pressure Overload Hypertrophy. Hypertension. [Accepted]
8. Lorbar M, Skalova K, Nabi A, Chung ES, Fenton RA, Dobson JG Jr, Meyer TE. Norepinephrine concentrations in the epicardial transudate reflect early changes in adrenergic activity in the isolated perfused heart. J Mol Cell Cardiol. 2000 Sep;32(9):1695-701
9. Woodiwiss AJ, Tsotetsi OJ, Sprott S, Lancaster EJ, Mela T, Chung ES, Meyer TE,
Norton GR. Reduction in myocardial collagen cross-linking parallels left ventricular
dilatation in rat models of systolic chamber dysfunction. Circulation. 2001 Jan
2;103(1):155-60.
10. Meyer TE, Chung ES, Perlini S, Norton GR, Woodiwiss AJ, Lorbar M, Fenton RA,
Dobson JG. Antiadrenergic Effects of Adenosine in Pressure Overload Hypertrophy.
Hypertension. 2001 Mar;37(3):862-868.
11. Fenton RA, Chung ES. Chronic ethanol enhances adenosine antiadrenergic actions in
the isolated rat heart. Alcohol Clin Exp Res. 2001 Jul;25(7):968-75.
12. Norton GR, Woodiwill AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP,
Meyer TE. Heart failure in pressure overload hypertrophy. The relative roles of
ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol. 2002 Feb
20;39(4):664-71.
13. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-
blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to
tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results
of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Anti-
TNF Therapy Against Congestive Heart Failure Investigators. Circulation. 2003 Jul
1;107(25):3133-40.
14. Lorbar M, Chung ES, Nabi A, Skalova K, Fenton RA, Dobson Jr JG, Meyer TE. Receptors subtypes involved in adenosine-mediated modulation of norepinephrine release from cardiac nerve terminals. Can J Physiol Pharmacol. 2004 Nov;82(11):1026-31.
15. Yu CM, Abraham WT, Bax JJ, Chung ES, Fedewa M, Ghio S, Leclercq C, Leon AR, Merlino J, Nihoyannopoulos P, Notabartolo D, Sun JP, Tavazzi L, on behalf of the PROSPECT Investigators. Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design. Am Heart J 2005;149:600-5
16. Chung ES, Menon SG, Daly KA, Atkinson J, Robertson R, Ibanez K, Kereiakes DJ Safety and Tolerability of Serial Home Infusions of Nesiritide for Advanced Heart Failure. Am J Cardiol 2006 May 1;97(9):1370-3.
17. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, Menon S, Nallamothu BK, Chan P. Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients with Ischemic Cardiomyopathy. J Am Coll Cardiol 2006 47: 1820-1827
18. Abbottsmith CW, Chung ES, Varricchione T, de Lame PA, Silver MA, Francis GS, Feldman AS, for the Prospective Evaluation of EECP in Congestive Heart Failure (PEECH) Investigators. EECP Improves Exercise Duration and Peak Oxygen Consumption in Older Patients with Heart Failure: a Subgroup Analysis of the PEECH Trial. Congestive Heart Failure 2006, Nov-Dec. 12(6):307-11.
19. Young JY, Chung ES, Mital A, Menon SG, Pastore J, Chow T, Kereiakes DJ. Early Revascularization and Guideline Based Medical Management Significantly Improves Left Ventricular Function and Short-Term Prognosis in Patients Presenting With Acute Myocardial Infarction and Severe Left Ventricular Dysfunction. J Invasive Cardiolo. 2006 Nov;18 (11): 540-543
20. Chung ES, Menon SG, Weiss R, Schloss EJ, Chow T, Kereiakes DJ, Pastore J. Attenuation of Cardiac Remodeling after Recent Myocardial Infarction through Biventricular Pacing. Congestive Heart Failure 2007, Jan-Feb. 13(1):9-15
21. Guo L, Chung ES, Snow R, Miller KL, Grossbart S, Casey D. Redefining Readmissions to Better Reflect the Clinical Course of Heart Failure Patients. American Journal of Medical Quality, 3 2007; vol. 22: pp. 98 - 102.
22. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, Menon S, Nallamothu BK, Chan PS. Microvolt T-Wave Alternans Identifies Patients with Ischemic Cardiomyopathy Who benefit From Implantable Cardioverter Defibrillator Therapy. J Am Coll Cardiol. 2007; 49: 50-58.
23. Curtis AB, Adamson PB, Chung ES, St. John Sutton M, Tang F, Worley S Biventricular vs. Right Ventricular Pacing in Heart Failure Patients with AV Block (BLOCK HF): Clinical study design and rationale. J Cardiovasc Electrophysiol. 2007 Sep;18(9):965-71. Epub 2007 Jul 27.
24. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ. Waller T, Chung E, Menon S, Nallamothu BK, and Chan PS. Microvolt T-Wave Alternans Identifies Patients With Ischemic Cardiomyopathy Who Benefit From Implantable Cardioverter-Defibrillator Therapy. J. Am. Coll. Cardiol. 2007;49;50-58
25. Chung ES, Guo L, Casey Jr DE, Bartone C, Menon SG, Saghir S, Mital A, Kereiakes DE. Relationship of a Quality Measure Composite to Clinical Outcomes for Patients with Heart Failure. Am J Med Qual. 2008 May-Jun;23(3):168-75.
26. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) Trial: Circulation. 2008 May 20;117(20):2608-16. Epub 2008 May 5.
27. Saghir S, Bartone C, Menon S, Brosmer J, Kereiakes J, Chung ES. Comparison of Ultrafiltration, Usual Care, and Usual Care plus Nesiritide in Acute Heart Failure. Congest Heart Fail. 2008 Nov-Dec;14(6):298-301.
28. Shahrokh Javaheri, Athar Malik, Jason Smith, Eugene Chung. The Natural History of CPAP-Emergent Central Sleep Apnea. In Press at Am J Respir Crit Care Med
29. Javaheri J, Malik A, Smith J, Chung ES. Adaptive Pressure Support Servo-Ventilation A novel treatment for sleep apnea associated with use of opioids J Clin Sleep Med. 2008 Aug 15;4(4):321-3.
30. Chan PS, Khumri T, Chung ES, Ghio S, Reid KJ, Gerritse B, Nallamothu BK, Spertus J. Echocardiographic Dyssynchrony and Health Status Response from Cardiac Resynchronization Therapy: Insights from the Predictors of Response to CRT (PROSPECT) Trial. In Review at JACC
31. Chung ES, Mazur W, Menon S, Schloss E, Chow T, Kereiakes DJ. Peri-Infarct Pacing with CRT in the Early Post Infarct Phase to Attenuate Long-term Remodeling. In press at Journal of Cardiovascular Translational Research. Published on line first at: http://springerlink.com/content/3733521h37vj3387/fulltext.pdf
32. Mazur W and Chung ES. Role of Echocardiography in Cardiac Resynchronization Therapy. In press at Current Cardiovascular Reviews.
Invited Reviews and Articles
1. Mazur W, Chung ES, Collins D, Choo J. Revolution in cardiac imaging: Real Time 3D Transesophageal Echocardiography. Cardiology, ACC member publication, Vol 37, No 9, September 2008. page 18-19.
Abstracts
1. Cuenoud HF and Chung ES. En Face Study of the Human Coronary Artery Intima. a. AHA Scientific Conference on Coronary Atherosclerosis and Thrombosis, Keystone, CO Feb 22-25, 1989. b. FASEB Journal, (1989) Vol.3, No 4, p.A1216
2. Chung ES, Leeman SE, Cuenoud HF. Focal Arteriolar Insudation is Decreased After Systemic Capsaicin treatment. FASEB Journal 1989; Vol 3, No 4: p A1014.
3. Cuenoud HF, Chung ES, Raungaard B, Majno G, Joris I. Pathology of Coronary Atherosclerosis, First Annual Massachusetts Conference on Cholesterol, Marlborough, MA Jan 31, 1990
4. Chung ES, Leeman SE, Cuenoud HF. International Symposium on Substance P and Related Peptides: Cellular and Molecular Physiology, Worcester, MA July 18-21, 1990.
5. Chung ES, Meyer TE, Dobson JG, Fenton RA. Adenosine's role in Adrenergic Subsensitivity seen with Left Ventricular Hypertrophy, 3rd International Congress on Heart Failure- Mechanisms and Management, Geneva, Switzerland, May 21-25, 1995.
6. Cuenoud HF, Giro EK, Chung ES, Wholey R, Heller LI, Laifer LI, Weiner BH. Prediction of Risk for Creatine Kinase Release by Immediate Examination of Directional Coronary Atherectomy Fragments. J Heart Failure, Abstracts of the 3rd International Congress on Heart Failure- Mechanisms and Management, Vol 2, No 1, Abst 1102, May 21-25, 1995.
7. Meyer TE, Chung ES, Dobson JG, Jr., Fenton RA, Aurigemma GP, Sadler DS, Gaasch WH. Adenosine Uptake Blockade Accelerates the Transition From Compensated to Decompensated Left Ventricular Hypertrophy,. 68th Scientific Sessions of the American Heart Association, Anaheim, CA, Nov. 13-16, 1995.
8. Aurigemma GP, Chung ES, Sadler DB, Gaasch WH, Meyer TE. Left Ventricular Geometry, Systolic Function, and Adrenergic Responsiveness in Rats with Pressure Overload Hypertrophy.. 68th Scientific Sessions of the American Heart Association, Anaheim, CA, Nov 13-16, 1995.
9. Chung ES, Meyer TE, Dobson JG, Jr., Fenton RA, Aurigemma GP, Gaasch WH. Chronic Adenosine Receptor Blockade Prevents Attenuation of Adrenergic Responsiveness in Left Ventricular Hypertrophy.. 45th Annual Scientific Sessions of the American College of Cardiology, Orlando, FL, March 24-27, 1996.
10. Sadler DB, Chung ES, Meyer TE , Rossini A, Gaasch WH, Aurigemma GP. Effects of Diabetes with or without Hypertension in the Genesis of Left Ventricular Hypertrophy in the Rat.. 45th Annual Scientific Sessions of the American College of Cardiology, Orlando, FL, March 24-27, 1996.
11. Chung ES, Perlini S, Fenton RA, Dobson JG , Jr., Meyer TE. Adenosine Uptake Blockade Prevents the Attenuation of Adrenergic Responsiveness in Pressure Overload Hypertrophy.. 69th Scientific Sessions of the American Heart Association, New Orleans, LA, Nov. 10-14, 1996.
12. Perlini S, Chung ES, Khoury EP, Fenton RA, Dobson JG , Jr., Meyer TE. 69th Scientific Sessions of the American Heart Association, New Orleans, LA, Nov. 10-14, 1996.
13. Meyer TE, Perlini S, Chung ES, Khoury EP, Fenton RA, Dobson JG , Jr. Adenosine Release Increases and Adenosine A1-receptors are Desensitized in Left Ventricular Hypertrophy.. 69th Scientific Sessions of the American Heart Association, New Orleans, LA, Nov. 10-14, 1996.
14. Perlini S, Khoury EP, Chung ES, Bartl F, Fenton RA, Dobson JG,Jr., Meyer TE. Prolonged Adenosine Exposure Elicits “Adrenergic Stunning” in Normal Hearts via a Protein Kinase C-Dependent Mechanism.. 46th Annual Scientific Sessions of the American College of Cardiology, Anaheim, CA, March 17-19, 1997.
15. Chung ES, Perlini S, Meyer TE, Gaasch WH, Aurigemma GP. Depressed Midwall Shortening Precedes Chamber Dysfunction in Pressure Overload.. 46th Annual Scientific Sessions of the American College of Cardiology, Anaheim, CA, March 17-19, 1997. 16. Perlini S, Khoury EP, Chung ES, Bartl F, Fenton RA, Dobson JG, Jr., Meyer TE. Left Ventricular Hypertrophy is Associated with Abnormal Adenosine A1-Receptor Signaling and Adenosine-Induced Protein Kinase C Activation.. 46th Annual Scientific Sessions of the American College of Cardiology, Anaheim, CA, March 17-19, 1997.
17. Meyer TE, Chung ES, Perlini S, Norton GR, Fenton RA, Dobson JG. Myocardial Adenosine Concentrations First Increase and the Decrease During the Transition from Compensated LV Hypertrophy to Myocardial Failure. 70th Scientific Sessions of the American Heart Association, Orlando, FL, Nov. 9-12, 1997.
18. Mela T, Pape LA, Weiner BH, Chung ES, Aurigemma GP, Meyer TE. Coronary Dimension to LV Mass Ration is Decreased in Non-ischemic Cardiomyopathy.. 70th Scientific Sessions of the American Heart Association, Orlando, FL, Nov. 9-12, 1997.
19. Chung ES, Perlini S, Fenton RA, Dobson JG, Aurigemma GP, Norton GP, Meyer TE. Adenosine A1-Receptor Desensitization is Associated with Systolic Decompensation in Pressure Overload Hypertrophy. 70th Scientific Sessions of the American Heart Association, Orlando, FL, Nov. 9-12, 1997.
20. Perlini S, Khoury E, Chung ES, Fenton RA, Dobson JG, Meyer TE. Adenosine Mediates Sustained Antiadrenergic Depression via Activation of Protein Kinase C in the Rat Heart.. 70th Scientific Sessions of the American Heart Association, Orlando, FL, Nov. 9-12, 1997.
21. Gemme D, Kent ET, Thompson M, Retalic T, Chung ES, Coleman KE, Meyer TE. Reduction of Hospital Readmission for Heart Failure Employing an Outpatient Program Aimed at Patient Self-reliance. Second Annual Scientific Meeting of Heart Failure Society of America, 1998.
22. Meyer TE, Perlini S, Chung ES, Norton G, Woodiwiss A, Dobson JG. Pressure overload hypertrophy is associated with attenuated adenosine A1-receptor signaling. 71st Scientific Session of the American Heart Association, Dallas, 1998.
23. Mela T, Norton GR, Woodiwiss A, McGinn RJ, Chung ES, Meyer TE. The effect of dipyridamole on survival in rats with pressure overload hypertrophy. 71st Scientific Session of the American Heart Association, Dallas, 1998.
24. Norton G, McGinn R, Mela T, Chung ES, Woodiwiss A, Aurigemma G, Gaasch WH, Meyer TE. The onset of LV failure in pressure overload hypertrophy is more closely related to deleterious chamber remodeling than to myocardial dysfunction. 47th Annual Scientific Session of the American College of Cardiology, Atlanta, 1998.
25. Monahan TS, SawmillerRA, FentonRA, Chung ES, Meyer TE, Dobson Jr. JG. Adenosine A2 receptor activation increases contractility in the isolated perfused heart. FASEB J 13(4):A110, 1999.
26. Dobson JG Jr., Fenton RA, Shea LG, Meyer TE, Chung ES. Myocardial membrane phosphorylation enhances the antiadrenergic action of adenosine. FASEB J 13(4): A790, 1999.
27. Chrysogelos ET, Gemme D, Coleman K, Chung ES, Meyer TE. Telemonitoring devices further improve outcomes of a multidisciplinary Heart Failure Outpatient Program. 3rd Annual Meeting, Heart Failure Society of America, Boca Raton, Sept, 1999.
28. Perlini S, Arosio B, Vandoni Pietro, Santambrogio D, Gagliano N, Chung ES, Palladini G, Parmeggiani L, Annoni G, Meyer TE, Ferrari AU. Gene expression of myocardial adenosine A1-receptor increases in compensated pressure-overload hypertrophy but decreases when the left ventricle fails. 72nd Scientific sessions of the American Heart Association, Atlanta, GA, Nov 1999.
29. Lorbar M, Siu M, Nabi A, Fenton RA, Dobson JG Jr., Chung ES. Hypertrophied and failing hearts can be preconditioned. 72nd Scientific sessions of the American Heart Association, Atlanta, GA, Nov 1999.
30. Meyer TE, Perlini S, Chung ES, Fenton R, Dobson JG Jr. Attenuation of adenosine A1-receptor signaling is related to the degree of chamber dysfunction in pressure overload hypertrophy. 72nd Scientific sessions of the American Heart Association, Atlanta, GA, Nov 1999.
31. Chung ES, Perlini S, Aurigemma GP, Meyer TE. Early identification of rats likely to develop heart failure in left ventricular hypertrophy. 72nd Scientific sessions of the American Heart Association, Atlanta, GA, Nov 1999.
32. Chung ES, Daly K, Peterson T, Warther T, Struharik K, Atkinson J, Menon S, Kereiakes D. Outpatient clinical practice heart failure disease management program reduces hospital resource utilization and costs. Heart Failure Society of America, Scientific Sessions, Boca Raton, FL Sept. 2002.
33. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double- blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Anti-TNF Therapy Against Congestive Heart Failure Investigators. 75nd Scientific sessions of the American Heart Association, Chicago, IL, Nov. 2002.
34. Chung ES, Peterson T, Daly K, Corser B, Menon S. Screening Tool for Obstructive Sleep Apnea in Patients with Heart Failure or Hypertension. Moderated poster presentation at the Heart Failure Society of America, 7th Annual Scientific Sessions, Las Vegas, NV, Sept 2003.
35. Chung ES, Bartlett T, Gubin S, Muse R, McGuire M. Heart failure patients at high risk of sudden cardiac death in clinical practice. Heart Failure Society of America, 7th Annual Scientific Sessions, Las Vegas, NV, Sept 2003.
36. Chung ES, Menon SG, Daly KA, Atkinson J, Robertson R, PetersonT, Gottwald M, Kereiakes DJ. Serial Home Infusions of Nesiritide: Safety and Efficacy Pilot Trial Results in Moderate to Severe Heart Failure. Heart Failure Society of America, 8th Annual Scientific Sessions, Toronto, ON, Sept 2004.
37. Menon SG, Chung ES, Gottwald M, McKracken M, Kereiakes. Blood Pressure Response to Nesiritide in Heart Failure Patients Treated with Multiple Neurohumoral Inhibitors. Heart Failure Society of America, 8th Annual Scientific Sessions, Toronto, ON, Sept 2004.
38. Chung ES, Menon SG, Chow T, Schloss EJ, Daly KA, Booth T, Kereiakes DJ. Enrollment in a Heart Failure Disease Management Program Increases the Likelihood of Defibrillator Implantation in the MADIT 2 Population. Heart Failure Society of America, 8th Annual Scientific Sessions, Toronto, ON, Sept 2004.
39. Bartone C, Chung ES, Daly KA, Beranek B, Menon SG, Kereiakes DK. Heart Failure Disease Management Program Eliminates Gender Bias in Care. Heart Failure Society of America, 9th Annual Scientific Sessions, Boca Raton, FL, Sept 2005. 40. McDonald M, Bartone C, Ellison B, Chung ES, Beranek B, Menon SG, Kereiakes DJ. Heart Failure Disease Management Program Delivering High Quality Care can be Cost-Effective for both the Health Care System and the Clinical Cardiology Practice. Heart Failure Society of America, 9th Annual Scientific Sessions, Boca Raton, FL, Sept 2005. 41. Chung ES, Bartone C, Daly KA, Beranek B, McDonald M, Menon SG, Ellison B, Kereiakes DK. Heart failure hospitalizations are dissociated from other quality of care outcomes in a heart failure disease management program. Heart Failure Society of America, 9th Annual Scientific Sessions, Boca Raton, FL, Sept 2005. 42. Chung ES, Young J, Mital A, Menon SG, Pastore J, Kereiakes DK. Effect of early revascularization and optimal medical therapy in patients with acute myocardial infarction and severe systolic dysfunction. Heart Failure Society of America, 9th Annual Scientific Sessions, Boca Raton, FL, Sept 2005. 43. Chung ES, Menon SG, Weiss R, Schloss EJ, Chow T, Kereiakes DJ, Pastore J. Attenuation of Cardiac Remodeling after Recent Myocardial Infarction through Biventricular Pacing. 55th Annual Scientific Sessions, American College of Cardiology. March 11-14th, 2006, Atlanta, GA.
44. Saghir S, Bartone C, Menon S, Barrows R, Chung ES. Comparison of ultrafiltration vs. nesiritide for acute decompensated heart failure. 55th Annual Scientific Sessions, American College of Cardiology. March 11-14th, 2006, Atlanta, GA
45. Chow T, Saghir S, Bartone C, Chung ES, Booth T, Chan PS, Mcrovolt T-wave alternans testing and QRS duration in patients with ischemic cardiomyopathy. 55th Annual Scientific Sessions, American College of Cardiology. March 11-14th, 2006, Atlanta, GA.
46. Chung ES, Bartone CL, Saghir SS, Menon SG, Barrows RJ, Brosmer JM, Daly KA, Kereiakes DJ. Inpatient Heart Failure Core Measures Improve Short-term Outpatient Outcomes. Heart Failure Society of America, 10th Annual Scientific Sessions, Seattle, WA 2006 47. Snow R, Guo L, Barrow L, Grossbart Stephen, Miller K, Chung ES, Casey D. The Effect of Heart Failure Trained Advocates on 30 and 60 day Readmissions. Heart Failure Society of America, 10th Annual Scientific Sessions, Seattle, WA 2006 48. Guo L, Chung ES, Snow R, Miller KL, Grossbart S, Casey D. Redefining Readmissions to Better Reflect the Clinical Course of Heart Failure Patients. Heart Failure Society of America, 10th Annual Scientific Sessions, Seattle, WA 2006 49. Guo L, Chung ES, Snow R, Miller KL, Grossbart S, Casey D. Redefining Readmissions to Better Reflect the Clinical Course of Heart Failure Patients. (Moderated Poster) 79th Scientific Sessions of the American Heart Association, Chicago, IL 2006. 50. Chan P, Chow T, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, Menon S, Nallamothu BK, Kereiakes D. Predictive Power of Microvolt T-Wave Alternans in Risk Stratifying MADIT-II and SCD-HeFT Eligible Patients. 79th Scientific Sessions of the American Heart Association, Chicago, IL 2006. 51. Chung ES, Guo L, Casey Jr DE, Bartone C, Menon SG, Saghir S, Mital A, Kereiakes DE. Relationship of a Quality Measure Composite to Clinical Outcomes for Patients with Heart Failure. AHA Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference 2007. May 9-11, 2007, Washington, DC.
52. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C. Results of the Predictors of Response to CRT (PROSPECT) Trial. Late Breaking Trials Session, Heart Failure Society of America, 11th Scientific Sessions, Washington, DC, September 16-19, 2007.
53. Saghir S, Bartone C, Barrows R, Menon S, Chung ES. Comparison of ultrafiltration to nesiritide therapy as a treatment modality for decompensated heart failure. JACC 2008;47A:85A (#1032-52).
54. Abraham WT, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Chung ES, Ghio S, Leclercq C. The Clinical Composite Response at 6 Months Predicts Subsequent Morbidity and Mortality PROSPECT (Predictors of Response to CRT) Trial. 57th Scientific Sessions of the American College Cardiology. Chicago, IL March 29th-April 1st, 2008.
55. Chung ES. Left Ventricular Pacing Post Myocardial Infarction. 5th International Stem Cell Therapy Symposium Madrid, Spain. April 2008
56. McDonald MB, Conley D, DyeL, Ellison B, Feldmann A, Schloss EJ, Chow T, Chung ES. Using Physician Quality Reporting Initiative Template for Screening Charts for Defibrillator Use in Heart Failure Patients. Scientific Sessions of The Heart Rhythm Society, San Francisco, May 2008.
57. McDonald M, Dye L, Conley D, Ellison B, Feldmann A, Chung ES. Evolving The Cardiology Electronic Medical Record: Implementing Quality Reporting And Clinical Guidelines. 9th Annual New Cardiovascular Horizons and Management of the Diabetic Foot and Wound Healing; New Orleans, La. September 2008
58. Cardiac Resynchronization Therapy in heart failure patients with narrow QRS complexes: results of a PROSPECT substudy. Featured presentation at the European Society of Cardiology, August, 2008
59. Stephens T, Bartone C, Menon S, Chung ES. An Algorithm Based Approach to Determining Target Volume Removal in Acute Heart Failure. Heart Failure Society of America, 12th Annual Scientific Sessions, Toronto, CA. September, 2008
60. Bartone C, Wagner J, Menon S, Greenwell M, Chung ES. Predictors of Serum Creatinine Elevation in Acute Decompensated Heart Failure Patients Treated with Ultrafiltration. Heart Failure Society of America, 12th Annual Scientific Sessions, Toronto, CA. September, 2008
61. Bartone C, Chung ES, Greenwell M, Wagner J, Joshi D, Menon S. Initiation of Ultrafiltration Within 24 Hours of a Heart Failure Admission Reduces Length of Stay and Readmission Rates. Heart Failure Society of America, 12th Annual Scientific Sessions, Toronto, CA. September, 2008
62. P.T. Mortensen, J. Herre, E. Chung, J. Bax, B. Gerritse, M. Kruijshoop, J. Murillo. The effect of Left Ventricular pacing site on Cardiac Resynchronization Therapy outcome: the results of a PROSPECT substudy. 69th Congress of the Italian Society of Cardiology, Rome, Italy. December 2008.
63. Chung ES, Katra R, Ghio S, Bax J, Gerritse B, Peterson B, Feldman D, Abraham W. Cardiac Resynchronization Therapy in Heart Failure Patients with LVEF > 35%. Submitted to Scientific Sessions of the Heart Rhythm Society. Dec 2008.
64. Chung ES, Dye L, Feldmann A, Schloss EJ, McDonald MA. Reasons for ICD underuse: EMR case-study. Submitted to Scientific Sessions of the Heart Rhythm Society. Dec 2008.
65. Chung ES, Dye L, Feldmann A, McDonald MA, Schloss EJ. Screening Charts for Defibrillator Use in Heart Failure Patients using EMR. Submitted to Scientific Sessions of the Heart Rhythm Society. Dec 2008.